Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients: a Single Center Prospective Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Adult patients over 18 years of age
• Lung transplant candidates with positive CMV IgG
• Anticipated to receive a lung transplant (both double lung and single lung)
Locations
United States
Florida
University of Miami
RECRUITING
Miami
Contact Information
Primary
Yoichiro Natori, MD
yxn138@med.miami.edu
3053556323
Backup
Lissett Moni
ltueros@med.miami.edu
3053555418
Time Frame
Start Date: 2024-12-03
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 100
Treatments
Prophylaxis guided by Cytomegalovirus-specific T cell Immunity
The immunological response of participants in this group will be followed for 1 year.
Related Therapeutic Areas
Sponsors
Collaborators: Eurofins Viracor, LLC
Leads: University of Miami